Search

Your search keyword '"Retuerto-Guerrero, M."' showing total 34 results

Search Constraints

Start Over You searched for: Author "Retuerto-Guerrero, M." Remove constraint Author: "Retuerto-Guerrero, M."
34 results on '"Retuerto-Guerrero, M."'

Search Results

2. AB1191 KL-6 AND IL-18 AS DIAGNOSTIC MARKERS FOR INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: OUTPERFORMING TRADITIONAL ASSESSMENTS FOR IMPROVED RISK STRATIFICATION AND EARLY DETECTION

3. AB1474 NINTEDANIB IN AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASE: REAL-LIFE EFFECTIVENESS, SAFETY AND TOLERANCE IN A SPANISH MULTICENTER STUDY

4. AB1000 ANIFROLUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS. SPANISH NATIONAL REGISTRY IN A REAL-WORLD SETTING

5. AB1039 CHARACTERIZATION OF A MULTICENTER COHORT OF PATIENTS WITH LUPUS NEPHRITIS UNDERGOING KIDNEY TRANSPLANTATION

7. AB0244 CANCER RISK STRATIFICATION IN IDIOPATHIC INFLAMMATORY MYOPATHIES: APPLYING IMACS GUIDELINES FOR ENHANCED SCREENING

8. POS0689 WINDOW OF OPPORTUNITY IN THE TREATMENT OF RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE WITH ABATACEPT. NATIONAL MULTICENTER STUDY OF 526 PATIENTS

9. POS0831 PREDICTIVE SIGNIFICANCE OF BIOMARKERS IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: INSIGHTS INTO PROGRESSION, LUNG VOLUME CHANGES, AND MORTALITY RISK

10. AB1483 NINTEDANIB IN PROGRESSIVE PULMONARY FIBROSIS. COMPARING SUBGROUPS IN CLINICAL PRACTICE. EXPERIENCE OF PULMONOLOGISTS AND RHEUMATOLOGISTS

11. AB0224 USE OF JAK INHIBITORS IN REAL CLINICAL PRACTICE: SAFETY ANALYSIS IN A THIRD LEVEL HOSPITAL

12. POS0853 ELDERLY SYSTEMIC SCLEROSIS. CLINICAL PRESENTATION AND OUTCOME

13. Déchiffrer la pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde en utilisant une analyse en cluster hiérarchique non supervisée : résultats d’une collaboration internationale

14. POS0035 INFLUENCE OF INTERSTITIAL LUNG DISEASE DURATION ON THE TREATMENT OF RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 392 PATIENTS WITH ABATACEPT

15. AB0416 SUBCUTANEUS VS INTRAVENOUS ABATACEPT IN RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 392 PATIENTS

16. OP0126 LONG-TERM FOLLOW UP OF ABATACEPT IN USUAL INTERSTITIAL PNEUMONIA ASSOCIATED TO RHEUMATOID ARTHRITIS. NATIONAL MULTICENTER STUDY OF 172 PATIENTS

18. POS1030 DNA-METHYLATION PROFILING IN THE BLOOD OF PATIENTS WITH RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE

19. INFLUENCE OF INTERSTITIAL LUNG DISEASE DURATION ON THE TREATMENT OF RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 392 PATIENTS WITH ABATACEPT.

21. FRI0132 EFFICACY AND SAFETY OF SWITCHING JAKINIBS IN RHEUMATOID ARTHRITIS

24. AB0319 ABATACEPT IN RHEUMATOID ARTHRITIS WITH INTERSTITIAL LUNG DISEASE. A MULTICENTRE STUDY OF 181 PATIENTS

26. AB1470-HPR Beliefs and satisfaction with golimumab as second anti tnf-alpha of patients with spondyloarthritis. go-beyond

27. AB0829 Persistence on golimumab as second line biological therapy in patients with spondyloarthritis (AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS). go-beyond, a retrospective study

30. SUBCUTANEUS VS INTRAVENOUS ABATACEPT IN RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 392 PATIENTS.

31. DNA-METHYLATION PROFILING IN THE BLOOD OF PATIENTS WITH RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE.

32. SAT0218 Efficacy of Bosentan for The Treatment of Digital Ulcers in Patients with Systemic Autoimmune Diseases

33. Nontuberculous Mycobacteria, Mucociliary Clearance, and Bronchiectasis.

34. Formation of Mycobacterium abscessus colonies in cellular culture in an in vitro infection model.

Catalog

Books, media, physical & digital resources